• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improving STEMI Reperfusion with Intracoronary Thrombolysis: A Way to "Go with the Flow".

作者信息

Davis DO Monique G, Blankenship James C

机构信息

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.

Division of Cardiology, University of New Mexico Health Sciences Center, MSC 10, Albuquerque, NM, 5550, USA.

出版信息

Cardiovasc Drugs Ther. 2024 Apr;38(2):209-210. doi: 10.1007/s10557-023-07471-y. Epub 2023 May 18.

DOI:10.1007/s10557-023-07471-y
PMID:37199883
Abstract
摘要

相似文献

1
Improving STEMI Reperfusion with Intracoronary Thrombolysis: A Way to "Go with the Flow".冠状动脉内溶栓改善ST段抬高型心肌梗死再灌注：一种“顺应血流”的方法。
Cardiovasc Drugs Ther. 2024 Apr;38(2):209-210. doi: 10.1007/s10557-023-07471-y. Epub 2023 May 18.
2
[The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].[ST段抬高型心肌梗死患者经皮冠状动脉介入治疗前冠状动脉内注射尼可地尔对心肌灌注及临床结局的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):26-33. doi: 10.3760/cma.j.issn.0253-3758.2017.01.006.
3
Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.冠状动脉内给药对ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗期间无复流现象的影响：一项网状Meta分析。
BMC Cardiovasc Disord. 2018 Jan 10;18(1):3. doi: 10.1186/s12872-017-0722-z.
4
Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).半剂量阿替普酶与直接经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死中的疗效和安全性：EARLY-MYO 试验（阿替普酶溶栓后早期常规冠状动脉造影与急性 ST 段抬高型心肌梗死直接经皮冠状动脉介入治疗的比较）。
Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27.
5
The Case Continues to Build: More Data that Intracoronary Thrombolysis Is Safe and Effective in STEMI.病例持续增多：更多数据表明冠状动脉内溶栓治疗对ST段抬高型心肌梗死安全有效。
Cardiovasc Drugs Ther. 2024 Apr;38(2):207-208. doi: 10.1007/s10557-024-07559-z. Epub 2024 Feb 6.
6
Fragmented QRS predicts reperfusion failure and in-hospital mortality in ST-Elevation myocardial infarction: a systematic review and meta-analysis.碎裂 QRS 波预测 ST 段抬高型心肌梗死再灌注失败和院内死亡率：系统评价和荟萃分析。
Acta Cardiol. 2020 Aug;75(4):298-311. doi: 10.1080/00015385.2019.1584696. Epub 2019 Apr 25.
7
Safety and efficacy of intracoronary thrombolytic agents during primary percutaneous coronary intervention for STEMI.急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗期间冠状动脉内溶栓药物的安全性和有效性。
Expert Rev Cardiovasc Ther. 2023 Mar;21(3):165-175. doi: 10.1080/14779072.2023.2184353. Epub 2023 Mar 3.
8
Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: Does time matter?经皮冠状动脉介入治疗前抗栓治疗对 ST 段抬高型心肌梗死患者冠状动脉再灌注的影响：时间是否重要？
Int J Cardiol. 2021 Feb 15;325:9-15. doi: 10.1016/j.ijcard.2020.09.058. Epub 2020 Sep 28.
9
Primary Percutaneous Coronary Intervention Versus In-hospital thrombolysis as Reperfusion Therapy in Early-Arriving Low-risk STEMI Patients.早期到达的低风险ST段抬高型心肌梗死患者中，直接经皮冠状动脉介入治疗与院内溶栓作为再灌注治疗的比较
Isr Med Assoc J. 2017 Jun;19(6):345-350.
10
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction.院前给予普拉格雷碾碎片对 ST 段抬高型心肌梗死患者的药效学影响。
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1323-1333. doi: 10.1016/j.jcin.2021.04.022.

本文引用的文献

1
Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial.在直接经皮冠状动脉介入治疗期间接受低剂量冠状动脉内溶栓治疗的ST段抬高型心肌梗死患者的长期预后：溶解试验的5年结果
J Thromb Thrombolysis. 2021 Jan;51(1):212-216. doi: 10.1007/s11239-020-02157-w.
2
Coronary microvascular obstruction in acute myocardial infarction.急性心肌梗死中的冠状动脉微血管阻塞。
Eur Heart J. 2016 Apr 1;37(13):1024-33. doi: 10.1093/eurheartj/ehv484. Epub 2015 Sep 12.
3
Intracoronary thrombolysis in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration.
经皮冠状动脉内溶栓治疗伴巨大管腔内血栓形成和抽吸失败的 ST 段抬高型心肌梗死患者。
Eur Heart J Acute Cardiovasc Care. 2014 Sep;3(3):229-36. doi: 10.1177/2048872614527008. Epub 2014 Mar 17.
4
Intracoronary thrombolysis in evolving myocardial infarction.进展性心肌梗死的冠状动脉内溶栓治疗。
Am Heart J. 1981 Jan;101(1):4-13. doi: 10.1016/0002-8703(81)90376-8.